FP7
K4DD
Kinetics for Drug Discovery (K4DD)
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 20,860,250
- EU contribution
- EUR 8,286,930
- Participants
- 19 from 6 countries
- Topic
- FP7_IMI-JU-04-2011-07
- Grant agreement
- 115366
Coordinated by Bayer Aktiengesellschaft (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Bayer Aktiengesellschaft | DEGermany | Coordinator | Not stated | PIC (1.00) |
| Universitat Wien | ATAustria | Participant | EUR 404,060 | known name (0.95) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| European ScreeningPort GmbH | DEGermany | Participant | EUR 141,492 | PIC (1.00) |
| Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschung Ev | DEGermany | Participant | EUR 405,500 | known name (0.95) |
| Hits Ggmbh | DEGermany | Participant | EUR 506,000 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Ruhr-Universitaet Bochum | DEGermany | Participant | EUR 404,999 | PIC (1.00) |
| Sanofi-Aventis Deutschland GmbH | DEGermany | Participant | Not stated | PIC (1.00) |
| Sierra Sensors GmbH | DEGermany | Participant | EUR 222,771 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Imperial College of Science Technology and Medicine | GBUnited Kingdom | Participant | EUR 534,757 | PIC (1.00) |
| Nxera Pharma UK Limited | GBUnited Kingdom | Participant | EUR 444,000 | PIC (1.00) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 667,549 | PIC (1.00) |
| University of Dundee | GBUnited Kingdom | Participant | EUR 1,000,899 | known name (0.95) |
| Stichting Lygature | NLNetherlands | Participant | EUR 639,643 | PIC (1.00) |
| Stichting Vu | NLNetherlands | Participant | EUR 819,999 | known name (0.95) |
| Universiteit Leiden | NLNetherlands | Participant | EUR 1,687,262 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 19 participants from 6 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.